-
A Chronology Of Geron's Imetelstat
Wednesday, September 14, 2016 - 12:47pm | 337Read More...Shares of Geron Corporation (NASDAQ: GERN) were trading at $2.08 Wednesday morning and are within two cents of its 52-week low of $2.06. Investors punished the stock on Monday after the bio-pharmaceutical company announced an update from a clinical trial involving Imetelstat, a potent and specific...
-
Traders Salivating For Action In Raptor Pharma: Here Are The Facts
Friday, August 19, 2016 - 10:06am | 349Read More...Raptor Pharmaceutical Corp. (NASDAQ: RPTP) is a bio-pharmaceutical company that focuses on the development of treatment for people affected by various diseases, including nephropathic cystinosis in adults and children. The stock was seeing some heavy buying action earlier this week on takeover...
-
Kite Pharma Falls 6%, Co. Confirms Review Of All Facilities Involving Sterile Material
Monday, April 18, 2016 - 10:21am | 154Read More...Shares of Kite Pharma Inc (NASDAQ: KITE) were trading lower by more than 6 percent Monday morning after the clinical-stage bio-pharmaceutical company confirmed that its facilities are undergoing a voluntary review. Kite Pharma said its cell therapy manufacturing facilities at the National Cancer...
-
Sinovac Biotech Confirms Acquisition Offer, Shares Spike
Monday, February 1, 2016 - 12:23pm | 161Read More...Shares of Sinovac Biotech Ltd. (NASDAQ: SVA), a China-based biopharmaceutical company that focuses on vaccines that protect against human infectious diseases, spiked higher by more than 18 percent at $5.94 on Monday. Sinovac Biotech announced earlier in the day that the Board of Directors...
